To further determine whether FBXW11 affects ovarian cancer cell sensitivity to olaparib through S100A11, we introduced plasmids overexpressing S100A11 into HBLV group and HBLV FBXW11group (Figs. S5C and D). The gene discussed is S100A11; the disease is ovarian carcinoma.